Mibampator (LY451395) Randomized Clinical Trial for Agitation/Aggression in Alzheimer’s disease

BACKGROUND: Mibampator, an AMPA receptor potentiator, was evaluated for treatment of agitation and aggression (A/A) in Alzheimer’s disease (AD). METHODS: Outpatients (n=132) with probable AD and A/A randomized to 12 weeks of double-blind treatment with 3 mg po mibampator or placebo were assessed usi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Trzepacz, Paula T., Cummings, Jeffrey, Konechnik, Thomas, Forrester, Tammy D., Chang, Curtis, Dennehy, Ellen B., Willis, Brian A., Shuler, Catherine, Tabas, Linda B, Lyketsos, Constantine
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938603/
https://ncbi.nlm.nih.gov/pubmed/23257314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1041610212002141
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia